Nortech Systems Incorporated
NSYS Healthcare Medical Devices
Nortech Systems Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $118.4 million, down 7.62% from fiscal 2024.
- Revenue
- +9.34%
- EPS
- −8.33%
- Free cash flow
- −1,567.2%
- Total debt
- −79.0%
Quarter to June 2026, against a year earlier
Follow NSYS
Alert me
Nortech Systems Incorporated (NSYS) P/E ratio
As of 5 November 2026, Nortech Systems Incorporated (NSYS) trades at a P/E ratio of 28.4×. Over the past ten years it has ranged from 0.0× (March 2026) to 443× (January 2017); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 4.0× | (74.47%) |
| FY2022 | 15.8× | 309.82% |
| FY2021 | 3.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 50.7× | — |
| FY2017 | 0.0× | — |
| FY2016 | 377× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 42.8× | 33.29% |
| Mar 2026 | 32.1× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TELA TELA Bio, Inc. compare | n/m |
| CVRX CVRx, Inc. compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| QTI QT Imaging Holdings, Inc. compare | n/m |
| NNOX Nano-X Imaging Ltd. compare | n/m |
| NSPR InspireMD, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| ELUT Elutia Inc. compare | 0.6× |
| NSYS Nortech Systems Incorporated | 28.4× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)